Pyridine, 2-chloro-4-(chloromethyl)- (9CI)

New Products

DL-Lactide L-Lactide PLGA 50:50 – PEG, DLG501P1 ,M.W:PLGA (Mw) : ~10,000 da, PEG (Mw) : ~1500 da Poly(DL-Lactide)-co-Glycolide, DLG852A, M.W:7,000 - 17,000 da, I.V: 0.16 - 0.24 dL/g Polycaprolactone, CL10015 , M.W: 190,000 – 240,000 da , I.V: 1.30 – 1.70 dL/g Lawesson’s Reagent methyl vinyl sulfone Pyridine, 3-[4-(hexyloxy)-1,2,5-thiadiazol-3-yl]-1,2,5,6-tetrahydro-1-methyl-, (2E)-2-butenedioate (1:1) 5-NITRONICOTINIC ACID 3-Pyridineacetonitrile, α-amino-, hydrochloride (1:1) TETRAHYDRO-2-(2-PROPYNYLOXY)-2H-PYRAN (1-Cyano-cyclobutyl)-carbamic acid tert-butyl ester ETHYL 2-[(3-FORMYL-4-ISOPROPOXYPHENYL]-4- METHY-1,3-THIAZOLE-5-CARBOXYLATE ROPIVACAINE USP RELATED COMPOUND B (HCL SALT) OPEN RING DESULFATED AZTREONAM (E-ISOMER) / AZTREONAM USP RELATED COMPOUND B HYOSCYAMINE RELATED COMPOUND A HYDROCHLORIDE ASCORBIC ACID IMPURITY D ((3S,4R,5S)-METHYL 3,4,5,6-TETRAHYDROXY-2-OXOHEXANOATE) LUMEFANTRINE N-OXIDE (2 BTL) Linagliptin (S)-(+)-N-(2,3-Epoxypropyl)phthalimide or (S)-N-Glycidylphthalimide 1-(2-Ethoxyethyl)-2-(piperidin-4-yl)-1H-benzo[d]imidazole 4-(2-chloroethyl)-α,α-dimethyl-) Benzeneacetic acid 4-Nitrophenyl Chloroformate 2-(4-Bromophenyl)-2-methylpropanoic acid